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1. Introduction
  Renal gene transfer is a promising option for treating 
various genetic and acquired kidney diseases[1-3]. So far, 
the most widely used method for gene delivery is through 
viral vectors[2-5]. However, the clinical use of viral vectors 
is limited because of the possible disadvantages such as 
immunogenic properties, inflammatory responses, and 
the difficulty of producing large amounts of pure virus. 
Therefore, non-viral technologies including chemical and 
physical approaches have attracted scientists' attention 
and are being rapidly developed. Compared with viral gene 
transfer, non-viral gene transfer is a very safe gene delivery 
method. Thus, many techniques have been employed to 
increase the efficacy of non-viral gene therapy recently.
  Ultrasound has become an arrest ing technique for 
physically altering tissue permeability properties for 
improved uptake of therapeutic agents, including DNA[6]. 
It has many attractive features for the clinical application 
of  renal  gene therapy,  such as non-invasive,  highly 
sophisticated, flexible, cost-effective, well tolerated, and 
so on. Additionally, ultrasound exposure in the presence 
of microbubbles can achieve site-specific transfer almost 
anywhere in the body. 
  Compared with other solid organs, the kidney offers 
accessibility to different routes. Many researches have 
reported the use of renal artery injections with ultrasound 
exposure for the DNA delivery to the kidney[7-9]. On the 
other hand, there are also some reports about the other 
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administration routes such as muscles injection[10,11], 
in t ravenous  in jec t i on [12,13],  and  rena l  pa renchymal 
injection[14] for the gene transfer of adeno-associated 
virus and other gene vectors. However, the gene transfer 
efficiency via different injective routes with ultrasound 
microbubbles aforementioned remains poorly understood. 
毬-galactosidase gene can be expressed correctly in a 
variety of organisms and more easily detected and monitored 
with high sensitivity. Therefore, in this study we used 毬
-galactosidase gene as a reporter gene to investigate 
the efficiency of ultrasound enhanced gene through four 
different delivery routes.
 
2. Materials and methods
2.1. Plasmid and ultrasound microbubble
  pLenti6/v5-GW/lacZ (Invitrogen, USA), a 10 128 bp 
control vector expressing 毬-galactosidase, was amplified 
in Escherichia coli, and then isolated and purified using 
DNA purification kit (Promega, USA) according to the 
manufac ture r ' s  manua l .  P lasmid  concen t ra t i on  was 
measured by the absorption at 260 nm with a Hitachi 
U-2000 (Hitachi, Japan). Optison襅(Amersham GE Health 
Care, Princeton, NJ, USA), which has been approved by the 
Food and Drug Administration for the clinical applications 
in the USA, is a microbubble ultrasound contrast agent 
comprising octafluoropropane gas bodies surrounded by 
albumin shells. Optison of 0.2 mL 10% (v/v) concentration 
or phosphate buffered saline (PBS) of equivalent volume was 
mixed with the lacz plasmids solutions, and gently shaken 
by hand immediately before injection.
2.2. Experimental animal and protocol
  Six-week old male Wistar rats were purchased from 
the academy of military medical sciences of the People's 
L ibera t ion  Army (PLA)  and housed  in  the  center  o f 
experimental animal, Chinese general hospital of PLA. The 
animals had free access to food and water. Twenty-five 
Wstar rats were randomly assigned into five groups: renal 
artery group (n=5), tail vein group (n=5), anterior tibial 
muscle group (n=5), renal parenchyma group (n=5), and PBS 
control group (n=5). In the first four groups, rats received a 
mixture of Optison microbubbles (0.2 mL) and lacz plasmids 
(25 毺g) via renal artery, tail vein, anterior tibial muscle, 
and renal parenchyma. In the control group, rats received 
a mixture of PBS (0.2 mL) and lacz plasmids (25 毺g) via 
renal artery. Immediately after the injection, an ultrasound 
transducer (Rich-Mar, Inola, OH, USA) was put on one side 
of the back close to the kidney and a continuous output of 1 
MHz at 5% power was applied for a total of 60 seconds, then 
the transducer was put on the other side of the back close 
to another kidney and treated it using the same procedure. 
All rats were sacrificed at day 3 after gene transfer; the 
efficiency of gene expression was evaluated on the basis of 
毬-galactosidase expression. To examine the possible side 
effects, immunohistological analysis of kidney, liver, and 
spleen sections were performed.
2.3. Detection of 毬-galactosidase expression
  The rat kidney samples, which were embedded in OCT 
compound (Sakura, USA) and frozen in liquid nitrogen, were 
cut into 8 毺m sections and then blown by a fan for 30 min 
at 20 曟. The sections were then fixed with 2% formaldehyde 
plus 0.2% glutaraldehyde in PBS on ice for 20 min, washed 
three times in PBS for 5 min at room temperature, and then 
incubated in the dark 6-18 h at 37 曟 in X-Gal solution 
(1 mg/mL X-Gal, 5 mM K4Fe(CN)6, 5 mM K3Fe(CN)6, 2 mM 
MgCl2 in PBS, pH7.4) and counterstained with eosin for 8-10 
s[5,15,16].
2.4. Immunohistochemical assay
  Fresh-frozen kidney sections were fixed with 100% acetone 
on ice for 20 min, washed, and transferred to X-gal staining 
solution. The sections stained with X-gal were blocked with 
1.5% H2O2 for 10 min, 5% bovine serum albumin/5% horse 
serum for 20 min, and incubated with rabbit anti-megalin 
(1:100, Santa Cruz, USA) over night at 4 曟, washed with PBS 
for 3 times, and stained with biotin conjugated anti-rabbit 
IgG for 2 h at 37 曟, and then the sections were washed with 
PBS for 3 times and stained with horseradish peroxidase-
labeled streptavidin (1:200, Vector Laboratories, USA) for 30 
min. After 3 washes with PBS, the sections were stained with 
3,3'- diaminobenzidine hydrochloride.
2.5. Statistical analysis 
  The data were analyzed with the SPSS 15.0 statistical 
package and presented as mean暲SD. Comparisons of 
characteristics among the four experiment groups were done 
using either one-way ANOVA or Kruskal-Wallis H test 
where appropriate. Statistical significance was defined as 
P<0.05.
3. Results
3.1. Pathological and biochemical changes in the rats after 
ultrasound-microbubble-mediated gene transfer via different 
routes
  We first determined the biochemical changes in the rats 
after the ultrasound-microbubble-mediated gene transfer 
via different routes. Liver and kidney function tests showed 
that the levels of alanine aminotransferase (ALT), aspartate 
aminotransferase (AST), blood urea nitrogen (BUN) and blood 
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serum creatinine (Cr) in each group rats were all within the 
normal range. The ALT and Cr in the renal artery and renal 
parenchyma groups were higher than that in the PBS control 
group (P<0.05), while the ALT and Cr in the tail vein and 
anterior tibial muscle group were lower than that in the PBS 
control group (P<0.05). No differences in the levels of AST 
and BUN were found between each group (P>0.05, Table 1). 
Next, we used periodic acid-Schiff staining to investigate 
the histological changes of kidney sections from each group. 
Interestingly, there was neither no evident pathological 
change in each group after the gene transfer (Figure 1). 
A B C
D E
Figure 1. Renal histological changes in the rats detected by periodic 
acid–Schiff (PAS) staining. 
No evident pathological changes were observed between each group 
after gene transfer. A: PAS staining of kidney sections from PBS 
control group. B: PAS staining of kidney sections from renal artery 
group. C: PAS staining of kidney sections from tail vein group. D: 
PAS staining of kidney sections from anterior tibial muscle group. E: 
PAS staining of kidney sections from anterior tibial muscle group. 
Magnification: ×200.
3.2. 毬-galactosidase expression of ultrasound-microbubble-
mediated gene transfer via different routes
  We next determined 毬-galactosidase expression in the 
kidneys of each group after the gene transfer via different 
routes. Rats from each group were injected via different 
routes using the procedure described in methods part 
and then were sacrificed 3 days after the gene delivery 
to evaluate 毬-galactosidase expression. The kidney 
sections from the control group showed no 毬-galactosidase 
expression (Figure 2A), whereas renal artery group, tail vein 
group, anterior tibial muscle group, and renal parenchyma 
group all showed positive 毬-galactosidase expression 
(Figure 2B, C, D, E), respectively.
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Figure 2. 毬-galactosidase expressions in the rats of ultrasound-
microbubble-mediated gene transfer via different routes. 
The rats were sacrificed on day 3, and the kidney sections were 
evaluated for 毬-gal expression. 毬-galactosidase expression could 
be observed only in tubules but not in glomeruli and interstitial 
area. A: 毬-galactosidase expression in the kidneys of PBS control 
group rats. B: 毬-galactosidase expression in the kidneys of renal 
artery group rats. C: 毬-galactosidase expression in the kidneys of 
tail vein group rats. D: 毬-galactosidase expression in the kidneys 
of anterior tibial muscle group rats. E: 毬-galactosidase expression 
in the kidneys of renal parenchyma group rats. Magnification, ×200. 
F: percentage of tubule interstitial positive area in these rats. G: 
percentage of positive tubules in these rats. *P <0.01 compared with 
renal artery group;▲P<0.01 compared with tail vein group; ﹟P<0.01 
compared with anterior tibial muscle group, n=5. 
  The 毬-galactosidase expression was only observed in 
cortical tubules but not in glomeruli and interstitial area. 
To confirm the efficiency of gene transfer for different 
administration routes, the percentage of the positive area and 
positive tubular was measured. The results of renal artery 
group, tail vein group, anterior tibial muscle group, renal 
parenchyma group, and the control group were summarized 
in Table 2 and Figure 2F, G. No 毬-galactosidase expression 
was detected in the extrarenal organs (data not shown), or in 
tubules up to 7 days (data not shown). 
3.3. Immunohistochemical analysis of megalin in kidney 
tissue
  Using immunohistochemical assay, we found that 毬
Table 1.
Serum GPT, GOT, BUN and Cr levels in the rats of ultrasound-microbubble -mediated gene transfer via different routes (n=5).
Group GPT(U/L) GOT(U/L) BUN(mmol/L) Cr(毺mol/L)
PBS control 25.95±3.04 174.63±10.32   9.48±2.24 51.10±7.56
Renal artery  37.67±3.79* 177.60±16.07 10.67±2.89  65.67±6.67*
Tail vein   26.33±4.04� 175.33±10.60   9.33±2.31   51.67±9.29�
Anteriortibial muscle  26.67±5.69� 177.67±15.31 10.67±1.94   54.33±5.86�
Renal parenchyma 31.33±5.51* 178.10±30.04 11.00±2.61  59.67±7.37*
*P<0.05 compared with PBS control group; �P<0.05 compared with renal artery group.
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-galactosidase was expressed in the rat renal cortex 
via renal artery injection. Megalin is a proximal tubular 
marker. Immunohistochemical staining revealed that both 
毬-galactosidase and megalin expressed on the proximal 
tubule of the kidneys (Figure 3)[17].
A B C
Figure 3. Immunohistochemical staining of megalin in kidney tissue. 
Optison microbubbles and lacz plasmids mixture were injected 
into the left kidney of wistar rats via renal artery, then the kidneys 
was exposed ultrasound for 3 min, and the rats were sacrificed on 
day 3, the kidney sections were evaluated for 毬-gal expression 
together with megalin immunohistochemical staining(A), megalin 
immunohistochemical staining(B), and 毬-gal expression(C).
4. Discussion
  Ultrasound is thought to act by transiently permeabilizing the cell 
membrane, thus increasing vector uptake. The mechanism behind 
this effect is cavitation, the formation and oscillation of gas bubbles, 
in a liquid medium. Optison is an ultrasound contrast agent, used 
for medical imaging, consisting of albumin microspheres, filled 
with octafluoropropane[18,19]. Recently, Optison has been used in 
several sonoporation studies[20,21], in which it is thought to lower 
the cavitation threshold and thus enhance the effects of ultrasound 
on gene transfer. Compared to similar available agents, Optison 
was superior for US-mediated gene transfer to skeletal muscle in 
vivo[22]. 
  It was shown that ultrasound-mediated microbubble destruction 
could all together enhance gene transfer into rat kidney in the four 
experimental groups. The efficiency of gene transferring in renal 
artery group rats was higher than that of tail vein group, anterior 
tibial muscle group and renal parenchyma group (4.10±0.33 vs. 
2.42±0.51, 1.70±0.53, 0.65±0.20, P<0.05), which was similar 
with the adeno-associated virus[5], while the percentage of 
positive tubules reach up to (52.62±1.62)%, thus suggested that 
the transduction efficiency may consistent with clinical usage. 
Remarkably, only the proximal tubular epithelial cells, but not the 
glomeruli or vascular cells, were transduced following in our study, 
which means that the tubular epithelial cells are highly susceptible 
to ultrasound, whereas the mechanism for this phenomenon is still 
unclear.
  Previous studies have concentrated on organs and tissues 
that are readily imaged by diagnostic ultrasound machines, 
including brain[23,24], skeletal muscle[25], heart[26,27], and 
kidneys[7-9]. As previous study reported, there are four 
different delivery routes of ultrasound and microbubbles 
into the kidney, such as via renal artery, via tail vein, 
via anterior tibial muscle, and via renal parenchyma. At 
present, more attention has been given to the route via ranal 
artery injecting[1]. We injected lacZ plasmid and Optison 
microbubble via these four routes above mentioned, and 
observed 毬-galactosidase expression on the proximal 
tubular epithelial cells of the rat kidney. Because of non-
invasion, peripheral vein and skeleton muscle administration 
may be a potential strategy for ultrasound enhancing gene 
transfer, although the gene transferring efficiency of renal 
artery group was highest.
  Plasmid mixed with Optison at the concentrations of 
50% and 100% (v/v) clearly showed matrix expansion and 
increase in glomerular diameter[9]. On the other hand, minor 
inflammation[28], transient elevation in cardiac enzymes[29] 
and temporary AV block[30] are also reported in animal 
experiments. In present study, we had not observed evident 
pathological and biochemical changes in each group rats, 
which may due to the short period observation, and long-
term experiments should be needed to evaluate the side 
effects of ultrasound enhance gene transfer.
  In summary, we injected Optison microbubbles and lacz 
plasmids mixture into the Wistar rats via renal artery, tail 
vein, anterior tibial muscle and renal parenchyma, and 
found that 毬-galactosidase expressed only in proximal 
tubular epithelial cells but not in glomeruli and interstitial 
cells. The gene transfer efficiency via renal artery was 
higher than that of tail vein, anterior tibial muscle and renal 
parenchyma. Compared with renal artery, microbubbles 
via tail vein and anterior tibial muscle are more convenient 
and less vulnerarious. Peripheral vein and skeleton muscle 
administration may therefore be a potential strategy for 
ultrasound enhancing gene transfer.
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